Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Olema Pharmaceuticals (OLMA)

Annual Return

Over the past 3 years, OLMA has had an average annual return of +22.87%, outperforming the benchmark SPY, which returned +22.45% annual.

Over the past 5 years, OLMA has had an average annual return of -17.65%, underperforming the benchmark SPY, which returned +13.88% annual.

Since Nov 19, 2020, OLMA has had an average annual return of -24.26%, underperforming the benchmark SPY, which returned +15.99% annual.

2026202520242023202220212020
-57.96%+328.74%-58.44%+472.60%-73.82%-80.53%-1.88%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+2.88%-5.91%-38.39%-3.35%-8.47%-20.32%-57.96%
2025+4.79%-28.47%-14.01%+37.29%+2.37%-19.39%+20.71%+6.20%+79.35%-8.36%+215.67%-11.73%+328.74%
2024-7.06%-4.89%-8.73%-10.13%-4.82%+11.74%+49.37%-26.99%+1.20%-3.45%-12.24%-42.37%-58.44%
2023+97.20%-15.11%-15.41%+38.14%+7.87%+74.69%-4.23%+17.34%+21.68%+7.62%+4.98%+0.56%+472.60%
2022-31.31%-27.21%-9.01%-40.16%+12.31%+42.29%+23.23%-21.29%-30.15%+36.23%-23.60%-14.68%-73.82%
2021-11.71%-5.96%-16.89%-15.46%-0.31%+0.07%-16.08%+27.42%-7.89%-2.03%-67.59%+6.94%-80.53%
2020+4.08%-5.73%-1.88%

Drawdown analysis of Olema Pharmaceuticals (OLMA)

The maximum drawdown for the OLMA was -96.26%, occurring on May 11, 2022. This drawdown has not yet recovered.

The current OLMA drawdown is -80.71%.

Since Nov 19, 2020 OLMA has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-96.26%Dec 1, 2020363May 11, 2022OngoingOngoingOngoing
-10.74%Nov 23, 20201Nov 24, 20204Dec 1, 20205
-0.20%Nov 19, 20201Nov 20, 20201Nov 23, 20202